Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Randomized Controlled Trial"
journalStr:"Annals of the rheumatic diseases"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=journalStr%3A%22Annals+of+the+rheumatic+diseases%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (151)
1
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies : a phase III randomised trial (contRAst 3)
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Taylor, P.
|
Weinblatt, M.
|
McInnes, I.
| +18
Wird geladen...
2
Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis : 16-week results from a randomized, placebo-controlled, phase 3 trial'
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Zhao, Y.
|
Huang, J.
CommentOn: Ann Rheum Dis. 2021 Aug;80(8):1014-1021. - PMID 33827787
Wird geladen...
3
Response to : 'Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial'' by Zhao and Huang
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Wei, J.
|
Kim, T.
|
Kishimoto, M.
| +3
CommentOn: Ann Rheum Dis. 2021 Aug;80(8):1014-1021. - PMID 33827787
Wird geladen...
4
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis : results at week 104 from a randomised placebo-controlled withdrawal study
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Landewé, R.
|
Poddubnyy, D.
|
Rahman, P.
| +6
Wird geladen...
5
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis : a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial
enthalten in:
Annals of the rheumatic diseases
| 2023
von
Brunner, H.
|
Foeldvari, I.
|
Alexeeva, E.
| +21
CommentIn: Int J Rheum Dis. 2023 Nov;26(11):2119-2121. - PMID 37563978
Wird geladen...
6
Response to : 'Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'' by Satis et al
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Ozen, S.
|
De Benedetti, F.
CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1362-1369. - PMID 32571870
Wird geladen...
7
Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever : results from the randomised phase III CLUSTER trial'
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Satış, H.
|
Aydemir, E.
|
İzmirlioğlu, K.
| +1
CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1362-1369. - PMID 32571870
Wird geladen...
8
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy : efficacy and safety results of a randomised controlled phase III study
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Feist, E.
|
Fatenejad, S.
|
Grishin, S.
| +6
Wird geladen...
9
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy : a double-blind, randomised, placebo-controlled phase 3 trial
enthalten in:
Annals of the rheumatic diseases
| 2022
von
van der Heijde, D.
|
Baraliakos, X.
|
Sieper, J.
| +9
Wird geladen...
10
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE) : a phase 2/3 randomised controlled trial
enthalten in:
Annals of the rheumatic diseases
| 2022
von
Bonelli, M.
|
Radner, H.
|
Kerschbaumer, A.
| +8
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Randomized Controlled Trial
Filter aufheben
Zeitschrift: Annals of the rheumatic diseases
Medienart
151
Aufsätze
145
E-Artikel
145
E-Ressourcen
6
Gedruckte Aufsätze
Zeitschriftentitel
Annals of the rheumatic diseases
Thema
151
Clinical Trial, Phase III
Randomized Controlled Trial
146
Journal Article
118
Research Support, Non-U.S. Gov't
107
Antirheumatic Agents
97
Multicenter Study
63
Antibodies, Monoclonal, Humanized
52
Methotrexate
52
YL5FZ2Y5U1
45
Antibodies, Monoclonal
27
DMARDs (biologic)
22
Rheumatoid Arthritis
20
Treatment
19
Adalimumab
19
Anti-TNF
19
FYS6T7F842
18
Immunosuppressive Agents
15
Tumor Necrosis Factor-alpha
14
Comparative Study
13
91X1KLU43E
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
30
2020-
109
2010-2019
11
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
151
Englisch
Haven't found what you're looking for?
Wird geladen...